Lawyers and Settlements
What are you looking for?
Home Page >> Hot Legal Issues >> Avelox

Avelox Antibiotic Linked to Tendon Ruptures

Were you looking for Levaquin Peripheral Sensorimotor Neuropathy lawsuits?

Avelox (moxifloxacin hydrochloride, is in a class of drugs known as fluoroquinolones, which includes Cipro and Levaquin. Avelox antibiotic is used to fight bacterial infections and is generally prescribed to treat bacterial sinusitis, chronic bronchitis, and community-acquired pneumonia. However, Avelox side effects include tendon ruptures and tears.


Send your Avelox claim to a Lawyer who will review your claim at NO COST or obligation.Get Legal Help Now

Avelox Tendon Rupture

Tendon RuptureAvelox antibiotic tendon ruptures can involve the Achilles heel, shoulder, hand, bicep or thumb. The risk of tendon ruptures is increased in patients older than 60, people who have received kidney, heart or lung transplants, and people on steroid therapy. Tendon swelling and tendon rupture can also occur in patients who do not have any of those risk factors. Furthermore, tendon ruptures can occur up to several months after treatment with Avelox is complete.

Avelox Side Effects

Avelox carries a black box warning alerting patients to the risk of Avelox tendon rupture and tendonitis (tendinitis). The warning came after Public Citizen—a public advocacy group—and the Illinois Attorney General's office petitioned the US Food and Drug Administration (FDA) to place a black box warning on Avelox.

Avelox has also been linked to an increased risk of liver injury including liver failure. This risk has been reflected on labeling information for the drug in Canada and in Europe.

According to Bayer's website, Avelox has been used to treat 109 million patients worldwide.

Avelox Tendon Rupture Legal Help

If you or a loved one has suffered a tendon rupture or tendon damage while taking the antibiotic Avelox, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.

Last updated on Mar-4-15


Woman Files Lawsuit Against the Makers of the Fluoroquinolone Avelox
Woman Files Lawsuit Against the Makers of the Fluoroquinolone Avelox Los Angeles, CA: Bayer and Merck are facing a product liability lawsuit filed by a woman from Nebraska who alleges she developed peripheral neuropathy while on the popular antibiotic Avelox.[READ MORE]

Fluoroquinolone Increases Risk for Permanent Nerve Damage, FDA Warns
Fluoroquinolone Increases Risk for Permanent Nerve Damage, FDA Warns Washington, DC: The Food and Drug Administration (FDA) has issued notice that it requires the drug labels and Medication Guides for all fluoroquinolone antibacterial drugs to be updated to better describe the serious side effect of peripheral neuropathy (PN). This serious nerve damage potentially caused by fluoroquinolones may occur soon after these drugs are taken and may be permanent [READ MORE]

"Avelox Has Taken My Life Away"
"Avelox Has Taken My Life Away" Bristol, RI: For anyone not familiar with the horrific side effects caused by Avelox, the following story seems unbelievable. How could an antibiotic destroy your health and family and leave you financially destitute? "Avelox has taken everything away from me," says Sue, a former nurse, mother of two and now divorced. "I put on my fake happy face for my kids, but as soon as they leave for school, I'm back in the couch. Whoever I was, is now gone. [READ MORE]


Publish your Avelox experience here for our readers to learn from.

Request Avelox Legal Help

First name:

Last name:

Email address:

Phone number(s):


Zip Code:

Describe your complaint:

Check Claim Status Advertise with us Legal Funding

Related Lawsuits

Legal Services:


FAQ | TOS | Privacy | Disclaimer | About Us | Contact Us | Press | Advertise | Member Login | Jobs | Site Map | View Mobile Website |

Better Business Bureau   CAALA   Best of the Web Approved   Public Justice

This work is licensed under a Creative Commons Attribution-NoDerivs 3.0 Unported License © 2001-2015 Online Legal Media. All rights reserved.